Forøget CPK, myalgi, myositis og i sjældne tilfælde rhabdomyolyse ved brug af proteasehæmmere, specielt i kombination med nukleosidanaloger.
Increased CPK, myalgia, myositis and rarely, rhabdomyolysis have been reported with protease inhibitors, particularly in combination with nucleoside analogues.